Loading...
PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ
Immunotherapy is revolutionizing the treatment paradigm for multiple myeloma (MM). Interferon (IFN)-γ is essential for immune responses, whereas immune checkpoint molecules, such as programmed cell death-1 ligand-1 (PD-L1), mitigate the beneficial anti-tumor immune responses. As HDAC inhibitors alte...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6443002/ https://ncbi.nlm.nih.gov/pubmed/30956773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26726 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|